Connect your AI

Sight Sciences, Inc. SGHT Long-Term Debt

Long-Term Debt at other companies

Johnson & JohnsonJNJ

$37.53B-2.2%

Bausch + LombBLCO

$5.01B+4.6%

Tarsus Pharmaceuticals, Inc.TARS

$72.6M+0.9%

Other financials

Income statement

Revenue$19.7M+12.5%

Gross profit$17.0M+12.5%

Operating income-$12.4M+10.4%

Net income-$13.0M+8.3%

EPS (diluted)-$0.24+14.3%

Balance sheet

Cash & equivalents$85.0M-21.9%

Total debt$40.9M+1.1%

Total equity$53.9M-30.6%

Total assets$109.7M-15.4%

Cash flow

Operating cash flow-$7.0M+39.4%

CapEx$60.0K—

Free cash flow-$7.1M+38.9%

Valuation

Market cap$294.9M+35.0%

Enterprise value$250.83M+59.0%

P/S3.7×+0.8×

Profitability

Gross margin86.2%+0.5pp

Operating margin-44.8%-10.2pp

Net margin-46.8%-9.6pp

FCF margin-31.9%+0.2pp

Returns & leverage

Return on equity-56.6%+4.3pp

Debt / equity0.8×+0.2×

Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebtNoncurrent.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sight Sciences, Inc.'s long-term debt?: Sight Sciences, Inc. (SGHT) reported long-term debt of $36.74M in Q1 2026.
How has Sight Sciences, Inc.'s long-term debt changed year-over-year?: Sight Sciences, Inc.'s long-term debt decreased by 7.2% year-over-year, from $39.58M to $36.74M.
What is the long-term trend for Sight Sciences, Inc.'s long-term debt?: Over 5 years (2020 to 2025), Sight Sciences, Inc.'s long-term debt has grown at a 4.7% compound annual growth rate (CAGR), from $31.96M to $40.3M.
What does long-term debt mean?: Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.